Please make JavaScript on and see this site.

Font size

Pmda - Pharmaceuticals and Medical Devices Agency

Menu

Close

Safety Alert & Recalls/ Review Reports/ Package Inserts etc.

Formats DL

About PMDA

About PMDA

Formats DL

Safety Alert & Recalls/ Review Reports/ Package Inserts etc.

Back

Back

For Regulatory Authorities
Regulations & Services of PMDA
Information about Approved Products in Japan
Safety Information
Advanced Efforts
FAQ
- Frequently Asked Questions (FAQ)
For Healthcare Professionals
Information for approved products in Japan
Safety information
FAQ
- Frequently Asked Questions (FAQ)
For Academia
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
Regulatory science
- The Science Board
FAQ
- Frequently Asked Questions (FAQ)
For Business
Regulations and services of PMDA
Information for approved products in Japan
Procedures in Japan
- Master File System
- Accreditation of Foreign Manufacturers
Advanced efforts
FAQ
- Frequently Asked Questions (FAQ)

Back

Drugs
Regulations and Services of PMDA
Information for apporoved products in Japan
- New drugs
Safety information
Procedures in Japan
- Master File System
- Accreditation of Foreign Manufacturers
Advanced efforts
Medical devices
Regulations and Services of PMDA
Information for apporoved products in Japan
- New devices
Safety information
- PMDA Medical Safety Information
Procedures in Japan
- Accreditation of Foreign Manufacturers
Advanced efforts
Quasi-drugs
Reviews and Related Services
Regulatory Procedures
- Accreditation of Foreign Manufacturers
Post-marketing Safety Measures
- Outline of Post-marketing Safety Measures
Regenerative medical products
Reviews and Related Services
Post-marketing Safety Measures
- Outline of Post-marketing Safety Measures
Advanced Efforts
- CPC (Cell Processing Center) Subcommittee
- Cellular and Tissue-based Products Subcommittee

Home
Regulatory Science/The Science Board/Standard Development
Regulatory Science Coordination
Measures for advanced science and technology
Subcommittee on AMR
The 2nd Subcommittee on AMR

Regulatory Science/The Science Board/Standard Development

The 2nd Subcommittee on AMR

日本語ページはこちら

Press Release

Date and Time: October 11, 2018 from 2pm to 4pm

Agenda / List of Handouts

Agenda

Lecture and Exchange of Opinions on Development of Antimicrobial Agents for AMR
- Challenge in Addressing Clinical Development of Antimicrobial Agents for AMR
  (Mr. Yoshisaburo Takahashi, General Manager, Clinical Research Planning Dept., Meiji Seika Pharma Co.,Ltd.)
Others

List of Handouts

Document 1 Lecture Materials (Mr. Yoshisaburo Takahashi)
Document 2 Summary of the 1st Subcommittee WG on AMR

Minutes

Minutes of the 2nd Subcommittee on AMR (in Japanese)【PDF:455KB】